PSA Today July 26: It's complicated / Eisai and AD / Canon, Chugai, Fujitsu, TEL results / Autos Up on Easing Tariffs / Fanuc / LINE's good Q2 - Nikkei -0.12%
Japan Market Comment by Pelham Smithers, Julie Boote, William Nestuk and Thao NguyenNikkei ¥22,586.87 (-¥27.38/ -0.12%); Topix ¥1,765.78 (+¥12.30/ +0.70%); ¥/$110.75
Tags: SoftBank (9984 JP), Fast Retailing (9983 JP), Toyota Motor (7203 JP), Obic (4684 JP), LINE (3938 JP), Advantest (6857 JP), Eisai (4523 JP), Biogen (BIIB US), Canon (7751 JP), Nikon (7731 JP), Ricoh (7752 JP), Toshiba (6502 JP), Apple (AAPL US), Chugai (4519 JP), Roche (ROG SW), Fujitsu (6702 JP), Tokyo Electron (8035 JP), Fanuc (6954 JP),Yaskawa (6506 JP), LINE MOBILE Corporation
Main Points at a Glance
• Equities mixed on results, BOJ
• Details of Eisai AD drug trial emerge
• Canon revises down full year OP
• Chugai FY18 2Q OP +36% YoY
• Fujitsu FY18 1Q overstates performance
• TEL misses inflated expectations
• Auto sector up on easing tariff tensions
• Fanuc falls but maintains ¥21,000
• LINE had a good FY18 Q2
Founded in 2009, Pelham Smithers Associates (PSA) provides market intelligence on Asian technology, focusing in particular on Japan. The industries covered by our team of specialists are: consumer electronics, telecomms, pharmaceuticals, internet, electronic parts and materials, automotive technology, retail and capital goods.
PSA produces both company and sector reports. The focus of PSA’s research is to identify winners and losers as new technologies impact the top and bottom lines of corporations. Critical to our research is the clear explanation of how these new technologies work and how they impact companies and industries.
The founding partners have worked closely together for twenty years and the team has more than doubled in size since 2012.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.